Déambu: Securing the Immediate Perioperative Walk: Creating and Validating a Score.

Sponsor
Ramsay Générale de Santé (Other)
Overall Status
Completed
CT.gov ID
NCT05111340
Collaborator
European Clinical Trial Experts Network (Other)
525
1
1
37.7
13.9

Study Details

Study Description

Brief Summary

The aim of this study is to set up a pre and postoperative ambulation score on a population of adult patients and undergoing outpatient surgery operated under locoregional anesthesia and sedation.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Perioperative score
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
525 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Securing the Immediate Perioperative Walk: Creating and Validating a Score.
Actual Study Start Date :
Apr 23, 2018
Actual Primary Completion Date :
May 1, 2021
Actual Study Completion Date :
Jun 12, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Adult patients undergoing sedation with or without associated local anesthesia

Behavioral: Perioperative score
Creation and validation of a perioperative walk score. The patient has to answer different items.

Outcome Measures

Primary Outcome Measures

  1. The validity of the perioperative walk score [1 day]

    The validity of the score will be assessed using the theory of item response (TRI). This theory is based on the correlations between the items of the score.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient over 18 years-old

  • Patient undergoing sedation with or without associated local anesthesia

  • Patient having giver their consent

  • Patient are benefiting from a social protection insurance

  • Patient hospitalized as part of the outpatient for ophthalmologic surgery or upper limb surgery, plastic surgery or surgery for implantation of a vascular access device

Exclusion Criteria:
  • Patient whose surgery is performed on the lower limbs

  • Patient with psychiatric disorders

  • Patient with dementia

  • Patient who has already participated in this same study (ex: cataract the second eye is made a few weeks after the first)

  • Patient's refusal to participate in the study

  • Protected patients: Adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision; Pregnant, breastfeeding or parturient woman; Hospitalized without consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital privé Arras les Bonnettes Arras France 62012

Sponsors and Collaborators

  • Ramsay Générale de Santé
  • European Clinical Trial Experts Network

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ramsay Générale de Santé
ClinicalTrials.gov Identifier:
NCT05111340
Other Study ID Numbers:
  • 2017-A02478-45
First Posted:
Nov 8, 2021
Last Update Posted:
Nov 8, 2021
Last Verified:
Oct 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 8, 2021